Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
Viral Structure00:56

Viral Structure

72.0K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
72.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PHGDH restricts porcine reproductive and respiratory syndrome virus replication by sustaining cellular antioxidant capacity and redox homeostasis.

Microbiology spectrum·2026
Same author

Porcine reproductive and respiratory syndrome virus hijacks the non-canonical enzymatic function of PHGDH to arrest autophagic flux for viral replication.

Autophagy·2026
Same author

Heterodimerization of PRRSV replicase membrane proteins nsp2 and nsp3 regulates their cytoplasmic tail binding to viral RdRp domain for sgRNA synthesis.

Journal of virology·2026
Same author

Modulation of the mevalonate pathway by TCR engagement regulates T follicular helper cell generation in homeostasis and autoimmunity.

Immunity·2026
Same author

Preparation and Epitope Identification of Monoclonal Antibodies Against African Swine Fever Virus pE120R.

Veterinary sciences·2026
Same author

The ASFV CD2v protein inhibits apoptosis by inducing proteasomal degradation of Bim<sub>EL</sub> via activation of the TPL2-MEK-ERK signaling pathway.

Journal of virology·2026

Related Experiment Video

Updated: Dec 2, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.9K

Quantitative Structure-Activity Relationship Machine Learning Models and their Applications for Identifying Viral

Julian Ivanov1, Dmitrii Polshakov1, Junko Kato-Weinstein1

  • 1CAS, A Division of the American Chemical Society, Columbus, Ohio 43210-3012, United States.

ACS Omega
|November 2, 2020
PubMed
Summary

Machine learning models identified potential COVID-19 drug candidates targeting viral proteases. These models screened FDA-approved drugs and chemical libraries, finding promising compounds for further therapeutic development against SARS-CoV-2.

More Related Videos

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

8.2K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

941

Related Experiment Videos

Last Updated: Dec 2, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.9K
Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

8.2K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

941

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Machine learning in medicine

Background:

  • The COVID-19 pandemic necessitates rapid identification of effective therapeutics.
  • Targeting key viral enzymes like 3 chymotrypsin-like protease (3CLpro) and RNA-dependent RNA polymerase (RdRp) is crucial for antiviral strategies.

Purpose of the Study:

  • To develop and apply machine learning models for predicting novel anti-SARS-CoV-2 drug candidates.
  • To identify potential therapeutics targeting 3CLpro and RdRp using computational screening.

Main Methods:

  • Assembled chemist-curated training sets from CAS data collections, integrating bioassay data.
  • Developed and optimized machine learning classification models.
  • Screened FDA-approved drugs and CAS REGISTRY substances for potential antiviral activity.

Main Results:

  • Identified numerous substances with predicted activity against 3CLpro or RdRp.
  • Some identified compounds were validated by existing bioassay data.
  • Several candidates are included in ongoing or upcoming COVID-19 clinical trials.

Conclusions:

  • Machine learning models can effectively assist in the drug discovery process for COVID-19.
  • This approach holds promise for identifying therapeutics against SARS-CoV-2 and other diseases.
  • Computational methods accelerate the search for novel antiviral agents.